Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04341818
Other study ID # FA219002_2
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 15, 2019
Est. completion date December 2021

Study information

Verified date April 2020
Source University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this randomized, double-blind, controlled intervention study with parallel groups is to investigate the effect of resistance training (2x/week for 10 weeks) with and without different goals of vitamin D intake on muscle strength, function and mass, oxidative stress parameters and the immune system in community dwelling persons. Participants (n = 100) will be community-dwelling older adults. After a preparticipation screening and a vitamin D blood investigation (vitamin D status below 75 nmol/L) participants will be distributed randomly but stratified by sex, age and initial vitamin D plasma levels to one of the 3 groups (Vitamin D daily + strength training, Vitamin D monthly + strength training, no Vitamin D + strength training).

Study participants are eligible if they are male or female with an age between 65 and 85 years and if their cognitive status as well as their physical fitness level allows to participate at the strength training sessions. Exclusion criteria comprise chronic diseases which contraindicate the training sessions, serious cardiovascular disease, diabetic retinopathy and manifest osteoporosis, a frailty index at or above 3, medication with anticoagulants or cortisone drugs, a regular strength training during the last six months and a vitamin D plasma concentration of 75nmol/L or above.

Primary outcome measure is the change in the handgrip strength. Secondary outcome measures comprise anthropometric data, functional performance tests, immunological and oxidative stress parameters, DNA/Chromosomal damage microbiota, metabolomics and the nutritional status.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date December 2021
Est. primary completion date August 20, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years to 85 Years
Eligibility Inclusion Criteria:

- Males and females between the age of 65 and 85 years

- Adequate mental condition in order to follow the instructions and to perform the resistance exercise independently (Mini-Mental-State >23)

- Independently mobile

Exclusion Criteria:

- Chronic diseases, which contraindicate a training participation

- Serious cardiovascular diseases (congestive chronic heart failure, severe or symptomatic aortic stenosis, unstable angina pectoris, untreated arterial hypertension, cardiac arrhythmias)

- Diabetic retinopathy

- Manifest osteoporosis

- Regular use of cortisone-containing drugs

- Regular strength training (> 1x / week) in the last 6 months before inclusion

- Vitamin D plasma level of 75 nmol/l or above

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Strength Training and Vitamin D monthly
For 4 wks 50.000 IU vitamin D is given as a monthly dose together with daily 400mg of calcium. Both as a supplement, followed by a 10 weeks resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D and calcium intake remain.
Strength Training and Vitamin D daily
For 4 wks 800 IU vitamin D is given as a daily dose together with daily 400mg of calcium. Both as a supplement, followed by a 10 weeks resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D and calcium intake remain.
Strength Training and no Vitamin D
For 4 wks no vitamin D is administered, followed by a 10 weeks resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the also no vitamin D is given. Over the whole study period participants get 400 mg calcium/day.

Locations

Country Name City State
Austria University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in handgrip strength (kg) Handgrip strength of the right hand will be measured to the nearest kilogram (kg) using a hand Dynamometer. Participants will be encouraged to perform a maximal contraction within approximately 4 to 5 s. After a rest of 60 s, participants will be asked to perform a second trial. The highest score of maximum voluntary contraction will be used for data analyses. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in chair stand test (repetitions within 30s) The maximum number of completed cycles of unsupported chair rises (from a seated to a fully erected position (hip and knees straightened)) completed within 30 s is counted automatically (Leonardo Mechanography). Force, acceleration, power, kinetic energy, potential energy, mass, total duration, time per iteration are reported as secondary parameters. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in muscle mass with BIA (kg) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in 6min walking test (distance in meter) Participants are instructed to walk alone as quickly as possible (without running) around a 30 m shuttle course as many times as possible within the time limit of 6 mins. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in the composition of gut-microbiota Gene sequencing of the 16S rRNA on the stool samples are performed to identify the microbes down to genus level as well as the microbial diversity and relative abundance. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in stool short-chain fatty acids (SCFAs) The stool short-chain fatty acids (SCFAs) will be extracted and quantitatively analysed by gas chromatography. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in oxidative stress marker such as malondialdehyde The investigators will consider changes in plasma concentrations of oxidative stress marker such as malondialdehyde. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in inflammatory marker (i.g. IL-6, TNF-alpha) The investigators will consider changes in plasma concentrations of Interleukin 1 (IL-1), IL-6, IL-8, IL-10, TNF-alpha baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in the metabolomic response The metabolomic response (ie all metabolites) to the interventions will be analyzed using both nuclear magnetic resonance (NMR) and mass spectrometry (MS) techniques. Patterns of metabolites will be evaluated with statistical techniques, ie discriminant analysis and principal component analysis. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in the amino acid pattern The plasma amino acid pattern will be assessed with HPLC-MS. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in DNA damage (%DNA in the tail) DNA damage will be assessed in lymphocytes, whole blood and urine in response to the interventions. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in chromosomal damage (number of micronuclei/1000 binucleated cells) Chromosomal damage will be assessed in lymphocytes in response to the interventions. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Secondary Change from baseline in RDA and DNA gene expression RNA and DNA gene expression will be assessed in response to the interventions. baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A